Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2024-03-28 | 2024-04-11 | 223835 |
TEVA-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2024-03-28 | 2024-05-03 | 223838 |
TEVA-METFORMIN | 500MG | TABLET | Actual shortage | 2024-03-28 | 2024-05-09 | 223841 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223844 |
TEVA-TELMISARTAN | 80MG | TABLET | Actual shortage | 2024-03-28 | 2024-05-23 | 223847 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-03-28 | 2024-05-30 | 223850 |
TEVA-CANDESARTAN | 32MG | TABLET | Actual shortage | 2024-03-28 | 2024-06-07 | 223853 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-28 | 2024-06-07 | 223856 |
TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223859 |
ACT METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-28 | 2024-05-09 | 223862 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-04-05 | 2024-06-07 | 224445 |
TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Actual shortage | 2024-04-05 | 2024-05-16 | 224448 |
TEVA-ATOMOXETINE | 25MG | CAPSULE | Actual shortage | 2024-04-05 | 2024-05-03 | 224451 |
TEVA-TAMOXIFEN | 10MG | TABLET | Actual shortage | 2024-04-05 | 2024-04-05 | 224454 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2024-04-11 | 2024-05-03 | 224883 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Actual shortage | 2024-04-11 | 2024-04-18 | 224886 |
TEVA-TOPIRAMATE | 25MG | TABLET | Resolved | 2024-04-11 | 2024-05-23 | 224889 |
TEVA-METFORMIN | 500MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-11 | 224892 |
TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Actual shortage | 2024-04-11 | 2024-05-23 | 224895 |
TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Actual shortage | 2024-04-11 | 2024-05-23 | 224898 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |